COLLEGIUM PHARMACEUTICAL INC (COLL)

US19459J1043 - Common Stock

37.51  0 (0%)

After market: 37.51 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
276.9M
-10.68%		463.9M
67.53%		566.767M
22.17%		595.18M
5.01%
EBITDA
YoY % growth
94M
-20.20%		203.6M
116.60%		324.717M
59.49%		393.73M
21.25%
EBIT
YoY % growth
25.1M
-55.34%		69.4M
176.49%		175.461M
152.83%		252.62M
43.98%		N/A
Operating Margin
9.06%14.96%30.96%42.44%N/A
EPS
YoY % growth
0.39
-48.68%		0.56
43.59%		1.18
110.71%		3.01
155.22%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.76
249.33%
Revenue
Q2Q % growth		150.44M
3.90%
EBITDA
Q2Q % growth		96.79M
EBIT
Q2Q % growth		55.468M
67.58%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.82
490.48%		0.670.1521.81%
Q3 2023
Q2Q % growth		 0.53
5,200.00%		0.530.000.57%
Q2 2023
Q2Q % growth		 0.34
6.25%		0.290.0515.94%
Q1 2023
Q2Q % growth		 -0.51
-215.91%		0.32-0.83-259.24%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 149.745M
15.54%		150.78M-1.035M-0.69%
Q3 2023
Q2Q % growth		 136.7M
7.64%		141.03M-4.33M-3.07%
Q2 2023
Q2Q % growth		 135.5M
9.72%		141.17M-5.67M-4.02%
Q1 2023
Q2Q % growth		 144.8M
72.79%		141.24M3.56M2.52%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -10.04% 0% -3.93%
Revenue0% 0.1% 0% 0.4%